☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
CTA
Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus
January 13, 2021
Alligator Bioscience Submits CTA for the P-II OPTIMIZE-1 Study of Mitazalimab
December 29, 2020
RedHill Biopharma Reports the Submission of CTA for P-II/III Study Evaluating Opaganib Against COVID-19 in Russia
June 11, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
